The latest news from Arcinova
FW Capital: Arcinova set to grow with £750,000 investmentArcinova was established in September 2015 by highly experienced life science entrepreneurs Ian Shott and Paul Ryan. In February 2016, it acquired a modern 15,000 sq.m. pharmaceutical Resear
Arcinova Q1 Newsletter 2017The Q1 newsletter, featuring important updates including the investment in equipment such as the Waters LC-MS system and expected installation of the 20L API streams.
Rural Funding Helps Arcinova Expand CapabilitiesWith the help of Arch Business, Arcinova have recently received approval for funding from the Rural Growth Network Fund. The £60,000 grant funding awarded from the Rural Growth Network Fu
Arcinova Invests in State of the Art LC-MS EquipmentDesigned for the most demanding bioanalytical quantitative UPLC-MS/MS applications, the latest Waters Xevo TQ XS has provided ARCINOVA with the ultimate in tandem quadrupole performance to ensure
French Tax Authority Grants Arcinova with R&D Organisation StatusArcinova has been recognised and approved by the French Tax Authorities as an organisation undertaking R&D activities. This will bestow significant benefits upon any French customers to
C&I Article: Master of ReinventionIn an article for C&I magazine on the 23rd November 2016, Maria Burke discusses Ian Shott's reputation for transforming businesses from failing companies into profitable, innovative organisati
C&I Article: The Whole PackageIn an article for C&I magazine on the 23rd November 2016, Ian Shott discusses future plans for the Alnwick site, transforming it into a profitable organisation, with potential sales of £20m b
Arcinova Q4 Newsletter 2016The Q4 newsletter, featuring important updates including the progression of our API development capabilities and the installation of the new GC-MS instrument and installation of the 5 Litre and 20
Arcinova Q3 Newsletter 2016We are proud to present our first quarterly newsletter, with important updates including the progression of our API development capabilities and the addition of GC-MS to broaden the scope of our o
Discover how Arcinova can help
We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.